Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders

被引：49

作者：

Mahoney, MJ ^{[1
]}

Saltzman, WM ^{[1
]}

机构：

[1] JOHNS HOPKINS UNIV, DEPT CHEM ENGN, BALTIMORE, MD 21218 USA

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1996年 / 85卷 / 12期

基金：

美国国家航空航天局;

关键词：

D O I：

10.1021/js9601602

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Alzheimer's disease involves substantial cholinergic cell deficits; other neurodegenerative diseases involve similar losses of certain cell populations. Optimal therapies may involve tissue replacement coupled with the controlled delivery of appropriate growth factors, such as nerve growth factor, to the graft site. In this review article we describe the kinetics of protein release from three modes of controlled protein delivery to transplants: delivery from a polymer matrix, delivery form polymeric microspheres, and delivery from genetically engineered cells. The efficacy and feasibility of each of these delivery strategies for potential treatment of patients diagnosed with neurodegenerative disorders is discussed.

引用

页码：1276 / 1281

页数：6

共 46 条

[11] SURVIVAL OF IMPLANTED FETAL DOPAMINE CELLS AND NEUROLOGIC IMPROVEMENT 12 TO 46 MONTHS AFTER TRANSPLANTATION FOR PARKINSONS-DISEASE [J].

FREED, CR ;

BREEZE, RE ;

ROSENBERG, NL ;

SCHNECK, SA ;

KRIEK, E ;

QI, JX ;

LONE, T ;

ZHANG, YB ;

SNYDER, JA ;

WELLS, TH ;

RAMIG, LO ;

THOMPSON, L ;

MAZZIOTTA, JC ;

HUANG, SC ;

GRAFTON, ST ;

BROOKS, D ;

SAWLE, G ;

SCHROTER, G ;

ANSARI, AA .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (22) :1549-1555

[12] Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain [J].

Fung, LK ;

Shin, M ;

Tyler, B ;

Brem, H ;

Saltzman, WM .

PHARMACEUTICAL RESEARCH, 1996, 13 (05) :671-682

[13] MORPHOLOGICAL RESPONSE OF AXOTOMIZED SEPTAL NEURONS TO NERVE GROWTH-FACTOR [J].

GAGE, FH ;

ARMSTRONG, DM ;

WILLIAMS, LR ;

VARON, S .

JOURNAL OF COMPARATIVE NEUROLOGY, 1988, 269 (01) :147-155

[14] GENETICALLY MODIFIED CELLS - APPLICATIONS FOR INTRACEREBRAL GRAFTING [J].

GAGE, FH ;

KAWAJA, MD ;

FISHER, LJ .

TRENDS IN NEUROSCIENCES, 1991, 14 (08) :328-333

[15] DEVELOPMENT OF POLY(ORTHO ESTERS) - A HISTORICAL OVERVIEW [J].

HELLER, J .

BIOMATERIALS, 1990, 11 (09) :659-665

[16] TRANSPLANTATION OF A POLYMER-ENCAPSULATED CELL-LINE GENETICALLY-ENGINEERED TO RELEASE NGF [J].

HOFFMAN, D ;

BREAKEFIELD, XO ;

SHORT, MP ;

AEBISCHER, P .

EXPERIMENTAL NEUROLOGY, 1993, 122 (01) :100-106

[17] NGF RELEASED FROM A POLYMER MATRIX PREVENTS LOSS OF CHAT EXPRESSION IN BASAL FOREBRAIN NEURONS FOLLOWING A FIMBRIA FORNIX LESION [J].

HOFFMAN, D ;

WAHLBERG, L ;

AEBISCHER, P .

EXPERIMENTAL NEUROLOGY, 1990, 110 (01) :39-44

[18] CONTROLLED RELEASE OF INTERLEUKIN-2 FROM BIODEGRADABLE MICROSPHERES [J].

HORA, MS ;

RANA, RK ;

NUNBERG, JH ;

TICE, TR ;

GILLEY, RM ;

HUDSON, ME .

BIO-TECHNOLOGY, 1990, 8 (08) :755-758

[19] BIODEGRADABLE POLYMER SYSTEMS FOR THE SUSTAINED-RELEASE OF POLYPEPTIDES [J].

HUTCHINSON, FG ;

FURR, BJA .

JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) :279-294

[20] HUMAN NERVE GROWTH-FACTOR PREVENTS DEGENERATION OF BASAL FOREBRAIN CHOLINERGIC NEURONS IN PRIMATES [J].

KOLIATSOS, VE ;

CLATTERBUCK, RE ;

NAUTA, HJW ;

KNUSEL, B ;

BURTON, LE ;

HEFTI, FF ;

MOBLEY, WC ;

PRICE, DL .

ANNALS OF NEUROLOGY, 1991, 30 (06) :831-840

← 1 2 3 4 5 →